Znn3bq.jpeg
²é¿´: 809  |  »Ø¸´: 5
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

¹Å¿É¤×

ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)

ÓÅÐãÇø³¤ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

[½»Á÷] FDAÅú×¼Spectral Diagnostics ¹«Ë¾¸Ä±ä¸Ã¹«Ë¾ToÖÎÁƸÐȾÐÔÐݿ˵ĺóÆÚÁÙ´²ÊÔÑé·½°¸ ÒÑÓÐ5È˲ÎÓë

Ô­ÎÄÁ´½Ó£ºhttp://www.reuters.com/article/2 ... ntent=Google+Reader
·­ÒëµÄ²»ºÃ£¬»¹Íû¾ÀÕýºÍº£º­£¬¹²Í¬Ìá¸ß

Spectral Diagnostics Inc said the U.S. health regulator approved a change in the design of a late-stage trial of its therapy for septic shock, to increase the study's ability to detect the treatment's effects.
Spectral Diagnostics£¨¹âÆ×Õï¶Ï£©¹«Ë¾±íʾ£¬ÃÀ¹úÎÀÉú¼à¹Ü»ú¹¹Åú×¼¸Ã¹«Ë¾ÖÎÁƸÐȾÐÔÐݿ˺óÆÚÁÙ´²ÊÔÑéÉè¼Æ·½°¸µÄ±ä¸ü£¬ÒÔÌá¸ßÁÙ´²Ñо¿Ë®Æ½´Ó¶ø½ÒʾÁÙ´²ÁÆÐ§¡£

The trial, named EUPHRATES, will now have two interim analyses instead of one.
¸ÃÁÙ´²ÊÔÑé³ÆÎªEUPHRATES£¬½«½øÐÐÁ½ÏîÁÙ´²ÖÐÆÚ·ÖÎö£¬¶ø·ÇÒ»Ïî¡£

It tests the company's Toraymyxin, which has been approved for therapeutic use in Japan and Europe, combined with the standard of care.
´ËÁÙ´²ÊÔÑéΪ½øÐиù«Ë¾ToraymyxinµÄÁÙ´²Ñо¿£¬¸ÃÒ©ÔÚÈÕ±¾ºÍÅ·ÖÞÒѾ­±»Åú×¼ÓÃÓÚÖÎÁƸÐȾÐÔÐݿˣ¬²¢½áºÏ±ê×¼»¤Àí½øÐÐÖÎÁÆ¡£

The company expects the trial to be fully enrolled by the end of 2014.
¸Ã¹«Ë¾Ô¤¼Æ2014ÄêÄêµ×½«Íê³ÉÁÙ´²ÊÔÑéÈ«²¿²¡ÀýµÄÈë×é¡£

Septic shock is a potentially dangerous fall in blood pressure because of the presence of bacteria.ÒòÓÐϸ¾ú´æÔÚ£¬¸ÐȾÐÔÐÝ¿ËÊÇѪѹϽµµÄDZÔÚ·çÏÕÒòËØ¡£

Based on the current rate of enrolment, Spectral will disclose results of the first analysis before the end of the first quarter of 2013, it said in a statement.
Ôڸù«Ë¾Ò»·ÝÉùÃ÷ÖУ¬»ùÓÚĿǰÁÙ´²ÊÔÑéµÄÈë×éÂÊ£¬¸Ã¹«Ë¾½«ÔÚ2013ÄêµÚÒ»¼¾¶Èǰ¹«²¼µÚÒ»ÆÚÁÙ´²ÊÔÑéµÄ·ÖÎö½á¹û£¬

Shares of the company closed at 24.5 Canadian cents on Tuesday on the Toronto Stock Exchange. ±¾Öܶþ£¬¸Ã¹«Ë¾¹É¼ÛÔÚ¶àÂ×¶à֤ȯ½»Ò×ËùµÄÊÕÅ̼ÛΪ24.5¼ÓԪÿ¹É¡£

[ Last edited by ¹Å¿É¤× on 2012-10-19 at 16:52 ]
»Ø¸´´ËÂ¥

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

» ²ÂÄãϲ»¶

·ÇÎáСÌìÏ£¬²Å¸ß¶øÒÑ£»·ÇÎá×ݹŽñ£¬Ê±¸³¶øÒÑ£»·ÇÎáíþ¾ÅÖÝ£¬ºê¹Û¶øÒÑ£»Èý·ÇÑÉ×ÎÞÃÎÖÁʤ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xunmeng1985

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¹ÅÇøÐÁ¿à£¡
̤ѩѰ÷£¬°Ù»¨Éî´¦£¡
6Â¥2012-10-20 12:25:52
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 6 ¸ö»Ø´ð

okitworks

ľ³æ (ÖøÃûдÊÖ)

ÓÅÐã°æÖ÷

Êׯª¿ÆÑпìѶ£¬ÆÄÊÜÆô·¢¡£
5Â¥2012-10-20 09:12:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ¿¼ÑÐÇóµ÷¼Á +5 ×ÓľÄÅ 2026-04-12 5/250 2026-04-12 22:15 by paopaotu326
[¿¼ÑÐ] µ÷¼Á +25 ²»·ê´º 2026-04-07 26/1300 2026-04-12 11:53 by ´óÁ¦Ë®ÊÖÁ¦´óÎÞÇ
[¿¼ÑÐ] 0854µ÷¼Á +12 ³¤¹­°Á 2026-04-09 13/650 2026-04-12 09:56 by ÄæË®³Ë·ç
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷±±¹¤Òµ´óѧ289 085602 +33 yangæÃ 2026-04-10 34/1700 2026-04-12 08:11 by Art1977
[¿¼ÑÐ] 22408µ÷¼Á315·Ö +3 zhuangyan123 2026-04-09 3/150 2026-04-12 00:25 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 22408µ÷¼ÁÇóÖú +7 ì±12 2026-04-09 9/450 2026-04-11 09:23 by ŶŶ123
[¿¼ÑÐ] 080500Çóµ÷¼Á +17 »ÆÓ 2026-04-06 17/850 2026-04-11 08:36 by zhq0425
[¿¼ÑÐ] Ò»Ö¾Ô¸¾©Çø985£¬085401£¬Óë±¾¿Æ×¨ÒµÒ»Ö£¬µç×ÓÐÅÏ¢¹¤³Ì£¬ +4 Ñô¹â¿ªÀʵÄÄк¢ 2026-04-10 4/200 2026-04-10 18:27 by shenrf
[¿¼ÑÐ] 085404 298·ÖÇóµ÷¼Á +10 ºôÀ²ºôÀ²ºôºôºô 2026-04-10 11/550 2026-04-10 16:44 by wangy0907
[¿¼ÑÐ] ¿¼ÑжþÂÖµ÷¼Á +8 ¹ÊÈË?? 2026-04-09 8/400 2026-04-10 09:44 by Çà÷duoduo
[¿¼ÑÐ] ±¾¿ÆÖ£ÖÝ´óѧ£¬Ò»Ö¾Ô¸»ª¶«Ê¦·¶´óѧ282Çóµ÷¼Á +23 Ðܸçxtk 2026-04-07 26/1300 2026-04-09 17:17 by 18446523
[¿¼ÑÐ] Ò»Ö¾Ô¸ÎäÀí³µÁ¾ 281 Çóµ÷¼Á +5 Éϰ¶Ñо¿Éú. 2026-04-07 5/250 2026-04-09 15:56 by onlyÖÜ
[¿¼ÑÐ] 311Çóµ÷¼Á +6 surte 2026-04-08 13/650 2026-04-09 14:00 by surte
[¿¼ÑÐ] ²ÄÁÏ307·ÖÇó´óÀÐ×éÊÕÁô +17 Hllºú 2026-04-07 17/850 2026-04-09 10:53 by liuhuiying09
[¿¼ÑÐ] Ò»Ö¾Ô¸0807 ÊýÒ»Ó¢Ò» 313 ÓÐûÓжþÂÖµ÷¼Á +11 emokidd 2026-04-08 12/600 2026-04-09 09:24 by wyf236
[¿¼ÑÐ] Çóµ÷¼Á +13 Æâluck 2026-04-07 13/650 2026-04-08 22:46 by Öí»á·É
[¿¼ÑÐ] 270Çóµ÷¼Á +3 031127 2026-04-06 4/200 2026-04-08 21:00 by ÄæË®³Ë·ç
[¿¼ÑÐ] Ò»Ö¾Ô¸¹þ¹¤´ó£¬³õÊÔ329£¬Çó»·¾³¿ÆÑ§Ó빤³Ìµ÷¼Á£¡ +11 ÓàδÐÁ 2026-04-06 11/550 2026-04-08 15:21 by screening
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷µç085401Çóµ÷¼Á +4 sunw1306 2026-04-07 4/200 2026-04-07 16:40 by à£à£à£0119
[¿¼ÑÐ] 22408 318·ÖÇóµ÷¼Á +4 ÇڷܵÄСÁý°ü 2026-04-06 6/300 2026-04-07 15:05 by Ö½º×555
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û